Christian Sirrenberg

This inventor holds 28 USPTO granted patents and 6 published patent applications, plus 10 CIPO patents and 21 EPO patents, primarily in Cancer Therapeutics. Top assignees: Merck Patent Gmbh, Merck Patent Gesellschaft MIT Beschrankter Haftung, Merck Patent Gesellschaft. Active years: 2005-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Sirrenberg. Retrieved from https://idiyas.com/inventor/christian-sirrenberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 6)

% Patents Active = 17.9

CIPO Patents = 10 (Patent Applications = 1)

EPO Patents = 21 (Patent Applications = 13)

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 82(Granted Patents)

Company Filing History:

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

1 out of 121

Merck Patent Gesellschaft

patents

4. 1 out of 100

Merck Patent Gesellschaft MIT Beschraenkter Haftung

patents

Years Active: 2005-2022

Loading Chart...

Areas of Expertise:

Protein Kinase Inhibitor

Chemotherapeutic Agent

7-Azaindole Derivatives

Quinazoline Derivatives

HSP90 Inhibitors

Indazole Derivatives

Triazole Derivatives

Oxindoles

Benzimidazole Derivatives

Pyrrole Derivatives

Chromenone Derivatives

Glycinamide Derivatives

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11246929 - Combination of a protein kinase inhibitor and an additional chemotherapeutic agent (2022-02-15),

2. 9725446 - 7-azaindole derivatives (2017-08-08),

3. 9266887 - 7-azaindole derivatives (2016-02-23),

4. 8981101 - 7-azaindole derivatives (2015-03-17),

5. 8906930 - Quinazoline derivatives (2014-12-09),

6. 8816070 - Triazole derivative as an HSP 90 inhibitor (2014-08-26),

7. 8791129 - Phenylquinazoline derivatives (2014-07-29),

8. 8722903 - Indazole derivatives for the treatment of HSP9O-induced diseases (2014-05-13),

9. 8546565 - Quinazolinamide derivatives (2013-10-01),

10. 8546390 - 6-(pyrrolopyridinyl) pyrimidin-2-ylamine derivatives and the use thereof for the treatment of cancer and AIDS (2013-10-01),

11. 8501754 - Quinazolinamide derivatives (2013-08-06),

12. 8410143 - Methylene urea derivatives (2013-04-02),

13. 8304416 - Chromenone derivatives (2012-11-06),

14. 8293891 - 4 (pyrrolopyridinyl)pyrimidin-2-ylamine derivatives (2012-10-23),

15. 8183279 - 1,3-dihydroisoindole derivatives (2012-05-22),

Title: Christian Sirrenberg - Innovative Inventor from Darmstadt

Introduction: Christian Sirrenberg is a renowned inventor hailing from Darmstadt, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Christian Sirrenberg holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials, showcasing his commitment to innovation and sustainability.

Career Highlights: With a career spanning over two decades, Christian Sirrenberg has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Christian Sirrenberg has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence in all his projects.

Conclusion: Christian Sirrenberg's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.